full free access: Guidelines Loading... American Society of Hematology Guidelines Epoetin and Darbepoetin

Guidelines

American Society of Hematology Guidelines

Epoetin and Darbepoetin
"American Society of Hematology/American Society of Clinical Oncology 2010 clinical practice guideline update on the use of epoetin and darbepoetin"The latest research and evidence-based clinical guidelines about the use of epoetin for the treatment of cancer-related anemia.

• Unabridged Guideline
• Data Supplement 
  
  "Future directions
  There is clear evidence regarding the ability of ESAs to increase
  Hb and avoid transfusions. There is also evidence of harm
  associated with their use. Perhaps the most pressing need for
  additional research is studies that further clarify the mechanisms of
  harm and, particularly, the groups of patients or circumstances of
  clinical use that are least associated with these risks. This understanding
  is paramount to the ability of clinicians to extend the
  benefit of these drugs while reducing the risks."